Zobrazeno 1 - 10
of 109
pro vyhledávání: '"E. Lidbrink"'
Publikováno v:
Cancer Research. 73:P3-13
Introduction: The treatment of metastatic breast cancer (MBC) lacks evidence beyond second or third line, but later lines are frequently used in clinical practice. The need for guidelines and studies with longer follow-up makes this area of particula
Autor:
P. Akesson, O. Jarlman, L. Samuelsson, U. Glas, K. Aspegren, L. Strender, C.-M. Rudenstam, G. Balldin, G. Edstrom, Nils Bjurstam, Laszlo Tabar, D. Hallberg, H. Wallberg, H. Lingaas, S. A. Larsson, A. Alveryd, Gunnar Fagerberg, M. Löfgren, Ingvar Andersson, A. Taube, E. Lidbrink
Publikováno v:
Cancer. 65:1671-1677
State of the art lightscanning of the breast was tested against mammography in 2568 women in a Swedish multicenter study. The study was in two parts. One was in women with symptoms from the breasts (the clinical study) comprising 3178 examined breast
Autor:
J, Bergh, T, Wiklund, B, Erikstein, E, Lidbrink, H, Lindman, P, Malmström, P, Kellokumpu-Lehtinen, N O, Bengtsson, G, Söderlund, G, Anker, E, Wist, S, Ottosson, E, Salminen, P, Ljungman, H, Holte, J, Nilsson, C, Blomqvist, N, Wilking
Publikováno v:
Lancet (London, England). 356(9239)
Chemotherapy drug distribution varies greatly among individual patients. Therefore, we developed an individualised fluorouracil, epirubicin, cyclophosphamide (FEC) regimen to improve outcomes in patients with high-risk early breast cancer. We then di
Publikováno v:
Karolinska Institutet
Autologous peripheral blood stem cell transplantation (APSCT) is increasingly used in the treatment of breast cancer. We report a patient who experienced septic shock, and after treatment with antibiotics, high-dose corticosteroids and mechanical ven
Objectives: To examine the implications of false positive results of mammography in terms of the time lag from screening and complete mammography to the point when women with false positive results are declared free of cancer; the extra examinations,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ae5ef1c9e4db4a93b446fb38b7a2f5a
https://europepmc.org/articles/PMC2349888/
https://europepmc.org/articles/PMC2349888/
Autor:
E, Lidbrink
Publikováno v:
Lakartidningen. 88(1-2)
Publikováno v:
Acta oncologica (Stockholm, Sweden). 30(8)
Autor:
Patrice Viens, Ahmad Awada, E. Lidbrink, H. Roche, D. Mery-Mignard, Corinne Veyret, Gilles Romieu, Véronique Diéras, Hervé Bonnefoi, Florence Dalenc
Publikováno v:
Journal of Clinical Oncology. 26:1070-1070
1070 Background: Larotaxel (L), a semi-synthetic taxoid, has shown preclinical and clinical activity against taxane-resistant BC, and it presents the ability to cross the blood brain barrier. In HE...
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.